112 related articles for article (PubMed ID: 20127718)
1. Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants.
Pajarinen J; Cenni E; Savarino L; Gomez-Barrena E; Tamaki Y; Takagi M; Salo J; Konttinen YT
J Biomed Mater Res A; 2010 Jul; 94(1):84-92. PubMed ID: 20127718
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors and aseptic loosening of hip endoprosthesis-a potential to respond against danger signals?
Lähdeoja T; Pajarinen J; Kouri VP; Sillat T; Salo J; Konttinen YT
J Orthop Res; 2010 Feb; 28(2):184-90. PubMed ID: 19725103
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants.
Tamaki Y; Takakubo Y; Goto K; Hirayama T; Sasaki K; Konttinen YT; Goodman SB; Takagi M
J Rheumatol; 2009 Mar; 36(3):598-608. PubMed ID: 19208601
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors in the interface membrane around loosening total hip replacement implants.
Takagi M; Tamaki Y; Hasegawa H; Takakubo Y; Konttinen L; Tiainen VM; Lappalainen R; Konttinen YT; Salo J
J Biomed Mater Res A; 2007 Jun; 81(4):1017-26. PubMed ID: 17415764
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of macrophage scavenger receptor MARCO in synovial membrane-like interface tissue in aseptic loosening of total hip replacement implants.
Zhao DS; Ma GF; Selenius M; Salo J; Pikkarainen T; Konttinen YT
J Biomed Mater Res A; 2010 Feb; 92(2):641-9. PubMed ID: 19235220
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of transforming growth factor-alpha and macrophage colony-stimulating factor/colony-stimulating factor-1R (c-fins) by multinucleated giant cells involved in pathological bone resorption at the site of orthopaedic implants.
Al-Saffar N; Revell PA
J Orthop Res; 2000 Sep; 18(5):800-7. PubMed ID: 11117303
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
8. Innate immune reactions in septic and aseptic osteolysis around hip implants.
Pajarinen J; Jamsen E; Konttinen YT; Goodman SB
J Long Term Eff Med Implants; 2014; 24(4):283-96. PubMed ID: 25747031
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of p53/BAK in aseptic loosening after total hip replacement.
Landgraeber S; Toetsch M; Wedemeyer C; Saxler G; Tsokos M; von Knoch F; Neuhäuser M; Löer F; von Knoch M
Biomaterials; 2006 May; 27(15):3010-20. PubMed ID: 16445975
[TBL] [Abstract][Full Text] [Related]
10. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.
Beraudi A; Stea S; Cremonini S; Visentin M; Toni A
Artif Organs; 2009 Jul; 33(7):538-43. PubMed ID: 19566730
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory response in 85 patients with loosened hip prostheses: a prospective study comparing inflammatory markers in patients with aseptic and septic prosthetic loosening.
Nilsdotter-Augustinsson A; Briheim G; Herder A; Ljunghusen O; Wahlström O; Ohman L
Acta Orthop; 2007 Oct; 78(5):629-39. PubMed ID: 17966022
[TBL] [Abstract][Full Text] [Related]
12. Expression of ADAM9 (meltrin-gamma) around aseptically loosened total hip replacement implants.
Ma GF; Liljeström M; Ainola M; Chen T; Tiainen VM; Lappalainen R; Konttinen YT; Salo J
Rheumatology (Oxford); 2006 Jul; 45(7):808-14. PubMed ID: 16418197
[TBL] [Abstract][Full Text] [Related]
13. [Low expression of Tlr-1, -2, -4 a il-2, -2r, -10, -10r and TgFb1 in pseudosynovial tissue collected at revision total knee arthroplasty for aseptic loosening].
Tománková T; Kriegová E; Fillerová R; Lužná P; Ehrmann J; Gallo J
Acta Chir Orthop Traumatol Cech; 2015; 82(1):67-75. PubMed ID: 25748664
[TBL] [Abstract][Full Text] [Related]
14. ERCC1 expression in aseptic loosening after total hip replacement.
Landgraeber S; von Knoch M; Löer F; Wegner A; Tsokos M; Schmid KW; Totsch M
J Biomed Mater Res A; 2010 Feb; 92(2):556-62. PubMed ID: 19235214
[TBL] [Abstract][Full Text] [Related]
15. Activation of periprosthetic connective tissue in aseptic loosening of total hip replacements.
Santavirta S; Xu JW; Hietanen J; Ceponis A; Sorsa T; Kontio R; Konttinen YT
Clin Orthop Relat Res; 1998 Jul; (352):16-24. PubMed ID: 9678029
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical analysis of periprosthetic osteolysis in aseptic loosening of hip arthroplasty].
Gravius S; Mumme T; Delank KS; Eckardt A; Maus U; Andereya S; Hansen T
Z Orthop Unfall; 2007; 145(2):169-75. PubMed ID: 17492556
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated expression of MIF by interfacial membrane fibroblasts and macrophages around aseptically loosened implants.
Pan X; Mao X; Cheng T; Peng X; Zhang X; Liu Z; Wang Q; Chen Y
J Surg Res; 2012 Aug; 176(2):484-9. PubMed ID: 22099602
[TBL] [Abstract][Full Text] [Related]
18. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
19. Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.
Diehl P; Hantke B; Hennig M; Tschesche H; Mittelmeier W; Schmitt M; Muehlenweg B
Int J Mol Med; 2004 May; 13(5):711-5. PubMed ID: 15067375
[TBL] [Abstract][Full Text] [Related]
20. [Our experience with revision total knee arthroplasty].
Musil D; Stehlík J; Stárek M
Acta Chir Orthop Traumatol Cech; 2005; 72(1):6-15. PubMed ID: 15860146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
